logo
[breadcrumb_custom]

Tag: (ORGO)

Industry

Organogenesis Holdings Inc (ORGO) Stock: A Year of Stock Market Ups and Downs

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Organogenesis Holdings Inc’s current trading price is -33.48% away from its 52-week high, while its distance from the 52-week low is 74.37%. The stock’s price range for this time frame has been between $1.79 and $4.70. The trading volume of the company’s shares in the Healthcare reached around 1.18 million for the day, which was evidently higher than the average daily volume of 0.76 million over the last three months. In terms of market performance, Organogenesis Holdings Inc had

TOST Stock
Industry

A Tale of Resilience: Organogenesis Holdings Inc Amid Stock Market Turbulence

Organogenesis Holdings Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $4.70 on 01/08/24, and the lowest price during that time was $1.79, recorded on 04/26/23. 52-week price history of ORGO Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Organogenesis Holdings Inc’s current trading price is -31.88% away from its 52-week high, while its distance from the 52-week low is 78.55%. The stock’s price range during this period has fluctuated between $1.79 and $4.70. Shares of the company, which operates

PNC Stock
Industry

Organogenesis Holdings Inc (ORGO) Stock: Uncovering a 52-Week Range and Trading Volume

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Organogenesis Holdings Inc’s current trading price is -24.34% away from its 52-week high, while its distance from the 52-week low is 98.33%. The stock’s price range for this time frame has been between $1.79 and $4.70. The trading volume of the company’s shares in the Healthcare reached around 0.66 million for the day, which was evidently lower than the average daily volume of 1.0 million over the last three months. Organogenesis Holdings Inc’s stock has had a calm market